Risk factors for SSc-ILD progression using the new PPF guideline and INBUILD PF-ILD criteria

被引：1

作者：

Hoffmann-Vold, Anna-Maria ^{[1
]}

Petelyska, Liubov ^{[2
]}

Fretheim, Havard ^{[1
]}

Barua, Imon ^{[1
]}

Becker, Mike ^{[2
]}

Bjorkekjaer, Hilde ^{[3
]}

Brunborg, Cathrine ^{[4
]}

Bruni, Cosmino

Phuong Phuong Diep ^{[1
]}

Dobrota, Rucsandra ^{[2
]}

Durheim, Michael ^{[5
]}

Elhai, Muriel ^{[2
]}

Jordan, Suzana ^{[2
]}

Langballe, Emily ^{[1
]}

Midtvedt, Oyvind ^{[1
]}

Mihai, Carima ^{[2
]}

Molberg, Oyvind ^{[1
]}

Distler, Oliver ^{[2
]}

机构：

[1] Dept Rheumatol, Oslo, Norway

[2] Univ Zurich, Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland

[3] Hosp Southern Norway, Dept Rheumatol, Kristiansand, Norway

[4] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway

[5] Oslo Univ Hosp, Dept Resp Med, Oslo, Norway

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA3471

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 7 条

[1] RISK FACTORS FOR SSC-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA
Hoffmann-Vold, A. M.
Petelytska, L.
Fretheim, H.
Barua, I.
Becker, M. O.
Bjorkekjaer, H. J.
Brunborg, C.
Bruni, C.
Diep, P. P.
Dobrota, R.
Durheim, M.
Elhai, M.
Jordan, S.
Langballe, E.
Midtvedt, O.
Mihai, C.
Molberg, O.
Distler, O.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 156 - 157
[2] PF-ILD and PPF criteria as predictors for mortality in RA-ILD
Phuong Phuong Diep
Langballe, Emily
Chaudhary, Asad
Garen, Torhild
Holm, Are Martin
Mangseth, Henrik
Molberg, Oyvind
Hoffmann-Vold, Anna-Maria
Durheim, Michael T.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[3] Factors Associated With Progression of Interstitial Lung Disease in Patients With Systemic Sclerosis (SSc-ILD)
Yosboot, A.
Muangchan, C.
Teerapuncharoen, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[4] HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) AND SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN FRANCE.
Nasser, M.
Rabiega, P.
Boussel, L.
Si-Mohamed, S.
Barbet, V
Marque, S.
Massol, J.
Revel, D.
Thivolet-Bejui, F.
Chalabreysse, L.
Maucort-Boulch, D.
Jouneau, S.
Hachulla, E.
Cottin, V
VALUE IN HEALTH, 2020, 23 : S717 - S718
[5] Factors prognostic of rapid progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Distler, Oliver
Avouac, Jerome
Hoffmann-Vold, Anna-Maria
Smith, Vanessa
Toenges, Gerrit
Alves, Margarida
Kuwana, Masataka
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[6] Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI)
Clukers, Johan
Homer, Kate
Lanclus, Maarten
Belmans, Dennis
Van Holsbeke, Cedric
De Backer, Wifried
De Backer, Jan W.
Khanna, Dinesh
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[7] EFFECT OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) AND RISK FACTORS FOR RAPID DECLINE IN FORCED VITAL CAPACITY: FURTHER ANALYSES OF THE SENSCIS TRIAL
Khanna, D.
Maher, T.
Volkmann, E.
Allanore, Y.
Smith, V.
Assassi, S.
Kreuter, M.
Hoffmann-Vold, A. M.
Kuwana, M.
Stock, C.
Alves, M.
Sambevski, S.
Denton, C. P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 102 - 103

← 1 →